Asymptomatic Troponin Elevation and Early Mortality Following Immune Checkpoint Inhibitor Therapy in Patients Without Cardiac Adverse Events
Subclinical troponin elevation is common in patients treated with ICIs. Higher troponin levels may be associated with earlier death; however, the underlying mechanisms remain unclear. Careful interpretation is needed and further research is required to clarify its prognostic value.
Authors
- Takuro Imaoka (ORCID: https://orcid.org/0000-0002-7274-1743)
- Kazuko Tajiri (ORCID: https://orcid.org/0000-0002-9759-1008)
- Atsuko Suzuki (ORCID: https://orcid.org/0000-0003-2662-2177)
- Yasunori Shibutani
Institutions
- University of Tsukuba (JP)
- National Cancer Center Hospital East (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-09-01
- DOI
- https://doi.org/10.21873/cdp.10479
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science